Agios Pharmaceuticals reported $0 in Pre-Tax Profit for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -19M 32M
Alexion Pharmaceuticals ALXN:US $ 827.7M 41M
Alnylam Pharmaceuticals ALNY:US $ -252.45M 74.23M
Amgen AMGN:US $ 2918M 77M
AstraZeneca AZN:LN 1478M 114M
Bayer BAYN:GR € 2049M 933M
Biomarin Pharmaceutical BMRN:US $ -15.97M 117.32M
Bluebird Bio BLUE:US $ -21.46M 181.06M
Bristol Myers Squibb BMY:US $ 4357M 361M
Daiichi Sankyo 4568:JP Y 41378M 60192M
Eli Lilly And LLY:US $ 1988.3M 137.6M
Exelixis EXEL:US $ 80M 20M
Gilead Sciences GILD:US $ 1804M 845M
GlaxoSmithKline GSK:LN 1541M 956M
Immunogen IMGN:US $ -22.37M 1.92M
JAZZ PHA JAZZ:US $ 267.46M 14.83M
Merk MRK:US $ 4096M 510M
Novartis NVS:US $ 4127M 426M
Pfizer PFE:US $ 5152M 170M
Regeneron Pharmaceuticals REGN:US $ 876M 24.6M
Sarepta Therapeutics SRPT:US $ -151M 133M
Seattle Genetics SGEN:US $ 639.41M 660.6M
Vertex Pharmaceuticals VRTX:US $ 870.63M 11.79M
YTE INCY:US $ 292.96M 894.15M